Safety and tolerability of nevirapine-based antiretroviral therapy in HIV-infected patients receiving fluconazole for cryptococcal prophylaxis: a retrospective cohort study

BACKGROUND: To compare the adverse events after initiation of nevirapine-based ART among HIV-infected patients who did not receive fluconazole (group A), received fluconazole 400 mg/week (group B), and received fluconazole 200 mg/day (group C). METHODS: A retrospective cohort study was conducted amo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Manosuthi, Weerawat, Chumpathat, Nopphanath, Chaovavanich, Achara, Sungkanuparph, Somnuek
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2005
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1199598/
https://ncbi.nlm.nih.gov/pubmed/16120209
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-5-67
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars